ClinicalTrials.Veeva

Menu

Prediction of Response to IUCD Associated Menorrhagia Using Doppler

A

Ain Shams University

Status

Completed

Conditions

Women's Health: Amenorrhea/Dysmenorrhea

Treatments

Device: Doppler

Study type

Interventional

Funder types

Other

Identifiers

NCT03794895
Yasmine's Protocol

Details and patient eligibility

About

Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia

Enrollment

156 patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women in chile bearing period (age 20-35 yrs ) with history of regular menstrual cycle presenting with recent onset of more then three months menorrhagia after IUCD "copper T 380 A" insertion

Exclusion criteria

  • history of bleeding tendency
  • history of abnormal uterine bleeding due to other causes
  • history of active liver disease
  • history of antiplatelet or anticoagulant intake in the last month
  • history of thyroid disease
  • history of endometritis
  • history of allergy to NSAIDs
  • Adenomyosis
  • women having contraindications to use NSAIDs e.g. peptic ulcer
  • Insulin dependant diabetes mellitus

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

156 participants in 1 patient group

Single arm clinical trial
Experimental group
Treatment:
Device: Doppler

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems